S. 1250 · 118th Congress · Senate

Drug-price Transparency for Consumers Act of 2023

Active· Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S1297; text: CR S1297-1298)
Introduced
Apr 20, 23
Passed Senate
Pending
Passed House
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

Drug-price Transparency for Consumers Act of 2023 or the DTC Act of 2023

This bill requires consumer advertisements for drugs and biologicals to include certain price information if the drug or biological is (1) covered under Medicare or Medicaid, and (2) required to include a risk summary under current law. The requirement does not apply to advertisements for drugs or biologicals with a wholesale cost of less than $35 for a one-month supply.

Each violation of this requirement is subject to a civil penalty of not more than $100,000.


Action Timeline

2
  1. APR 20, 2023IntroReferral

    Introduced in Senate

  2. APR 20, 2023IntroReferral

    Read twice and referred to the Committee on Finance

    (Sponsor introductory remarks on measure: CR S1297; text: CR S1297-1298)

    1297Yea
    1298Nay
    0NV

Committees

1

Finance Committee

ssfi00

Referred: Apr 20, 2023

Active